The Korea-based thermal ablation system manufacturer made both products commercially available in the U.S.
According to a news release, the technologies help to modernize the standard of care for minimally invasive practices.
“The world’s medical device market is showing remarkable growth driven by cutting-edge minimally invasive technology and its industrial value is limitless,” said RF Medical CEO Mike Jun. “RF Medical is working diligently in an effort to keep pace with the advanced medical market. Improving the health and safety of mankind is our top priority and we are dedicated to carrying our mission as a leading medical device company through continuous investments in superior workforce and R&D.”
Mygen M-3004 enables a combination of monopolar and bipolar mod…